AGIOS PHARMACEUTICALS, INC. Public Float
AGIOS PHARMACEUTICALS, INC. (AGIO) had Public Float of $1.91 billion as of 2025-06-30, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-12
- 2025-06-30: Entity Public Float $1.91B.
- 2024-06-30: Entity Public Float $2.42B.
- 2023-06-30: Entity Public Float $1.56B.
- 2022-06-30: Entity Public Float $1.20B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.91B 10-K · filed 2026-02-12 |
| 2024-06-30 | $2.42B 10-K · filed 2025-02-13 |
| 2023-06-30 | $1.56B 10-K · filed 2024-02-15 |
| 2022-06-30 | $1.20B 10-K · filed 2023-02-23 |
| 2021-06-30 | $3.27B 10-K · filed 2022-02-24 |
| 2020-06-30 | $3.28B 10-K · filed 2021-02-25 |
| 2019-06-28 | $2.56B 10-K · filed 2020-02-19 |
| 2018-06-29 | $4.27B 10-K · filed 2019-02-14 |
| 2017-06-30 | $2.15B 10-K · filed 2018-02-14 |
| 2016-06-30 | $1.19B 10-K · filed 2017-02-16 |
| 2015-06-30 | $3.09B 10-K · filed 2016-02-26 |
| 2014-06-30 | $876.21M 10-K · filed 2015-02-24 |
| 2013-07-24 | $314.47M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |